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Review of Experimental Carcinogenesis
by Compounds Related to Vinyl Chloride
by Kenneth C. Chu* and Harry A. Milmant
The experimental carcinogenesis results on six compounds related to vinyl chloride are
reported. Vinylidene chloride, given by inhalation, was carcinogenic in male CD-1 mice, male CD
rats, Sprague-Dawley rats and male Swiss mice. Trichloroethylene, given by gavage and
inhalation, was carcinogenic in the B6C3F1 mice. When given by gavage, perchloroethylene was
carcinogenic in the B6C3F1 mice, and dichloroethane was carcinogenic in Osborne-Mendel rats
and B6C3F1 mice. Dibromoethane, given by gavage and inhalation, was carcinogenic in B6C3F1
mice, F344 rats and Osborne-Mendel rats. Finally, epichlorohydrin was carcinogenic in male
Sprague-Dawley rats and B6C3F1 mice.
Introduction
Since the carcinogenicity of vinyl chloride (VC)
was demonstrated in experimental (1) and epid-
emiologic studies (2), data on the potential carcino-
genicity of vinyl chloride structural analogs and
related compounds have beenincreasing. This paper
will attempt to review the experimental carcinoge-
nicity data on a number ofthese compounds, while
another paper (3) will discuss the epidemiologic
results.
H /Cl
\C=C
H H
Vinyl chloride
VC
Cl Cl
I I
H-C-C-H
I I
H H
1,2-Dichloroethane
DCE
H CI
C=C
H Cl
Vinylidene chloride
VDC
Br Br
I I
H-C-C-H
I I
H H
1,2-Dibromoethane
DBE
Cl ,Cl
C=C
H Cl
Trichloroethylene
TCE
Cl /l
C=C
Cl Cl
Tetrachloroethylene
PCE
H H H
I I I
H-C-C-C-Cl
\/ I
O H
*National Cancer Institute, Bethesda, Md. 20205. Epichlorohydrin
tEnvironmental Protection Agency, Washington D.C. 20460. EPC
October 1981 211Results
Vinylidene Chloride (VDC)
A summary of some of the carcinogen bioassays
of vinylidene chloride is given in Table 1. The
strongest evidence ofa carcinogenic effect was in a
bioassay involving Swiss mice performed by Maltoni
et al. (4, 5). In this study, 24/150 dosed male mice
had kidney tumors as compared to 0/190 in the
controls. In the study by Lee et al. (6, 7), dosed
CD-1 mice and CD rats had two or three liver
angiosarcomas. Since this type of tumor was in-
duced by vinyl chloride in humans and rodents and
the study was terminated after only one year, the
results are viewed as biologically significant. In an
inhalation study in Sprague-Dawley rats by Maltoni
et al. (4, 5), increases in mammary gland tumors in
the dosed animals were reported. However, these
incidences did not follow a dose-response relation-
ship.
In contrast to these positive studies, a number of
nonpositive two-year carcinogen bioassay studies
have been reported (6-9). Most notable is this initial
report that preliminary evaluations of vinylidene
chloride in a two-year National Toxicology Pro-
gram (NTP)/NCI bioassay ofFischer344rats, given
at 2-10 mg/kg ofbody weight and of B6C3F1 mice,
given at 1-5 mg/kg ofbody weight, did not indicate
any significant increased incidences oftumors inthe
dosed animals as compared to controls.
Trichloroethylene (TCE)
A summary of some of the carcinogen bioassays
oftrichloroethylene isreported inTable 2. In B6C3F1
mice, this compound, given by gavage, was found
to be carcinogenic, inducing hepatocellular tumors
(10). In confirmation of this finding, an inhalation
study in B6C3F1 mice, performed by Biotest Labo-
ratories, gave similar results (11).
Bioassays ofTCE were nonpositive in two strains
of rats, the Sprague-Dawley and Osborne-Mendel
(10-12). Additional NTP/NCI carcinogen bioassays
are under way in five strains ofrat and the B6C3F1
mice to examine species and strain differences.
Tetrachloroethylene (Perchloroethylene)
PCE
The carcinogen bioassay results of testing PCE
are given in Table 3. In B6C3F1 mice, this com-
pound, given by gavage, was carcinogenic inducing
hepatocellular tumors.
Studies in two strains of rats, Osborne-Mendel
and Sprague-Dawley, produced no carcinogenic ef-
fects (13-14). Additional carcinogen bioassays in
four strains ofrats and the female B6C3F1 mice are
currently underway at NTP/NCI.
1,2-Dichloroethane (DCE)
The experimental carcinogenicity results oftest-
ing DCE are given in Table 4. In B6C3F1 mice, the
Table 1. Bioassays of vinylidene choride (VDC).
Route Dose Dosing period Group Target site (tumor
Species/Stra (vehicle)b Sex ppm (duration), wk size incidences)d Reference
or mg/kgc
Mouse, CD-I1 Inhal M 55 52D(52) 36 Liver, hemangiosarcoma (6,7)
Inhal
Inhal
0
F 55
0
M 55
0
F 55
0
M 150
100
50
25
10
0
F 150
100
50
25
10
0
D t
52D(52)
,,
52D(52)
it
52D(52) DI
52D(life)
it it
it ..
it ..
it ..
it it
52D(life)
It it
It ..
it it
it It
it It
36
36
36
36
36
36
36
60
30
30
30
30
100
60
30
30
30
30
100
(2/35 0/26)
Liver, hemangiosarcoma
(1/35 0/36)
Hemangiosarcoma
(2/36 0/35)
NSC
NSC
(6,7)
(4,5)
Mammary gland
(nondose response)
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Route Dose Dosing period Group Target site (tumor
Species/Stra (vehicle)b Sex ppm (duration), wk size incidences)d Reference
or mg/kg'
Inhal M 25
10
0
F 25
10
0
Gav M 20
(Olive oil) 10
5
0
F 20
10
5
0
Inhal M 25
0
F 25
0
Gav M 10
(Corn oil) 2
F 10
2
0
Gav M 5
(Corn oil) 1
0
F 5
1
0
Inhal M 75
25
0
F 75
25
0
Water M 200
100
60
0
F 200
100
60
0
Inhal M 200-100
0
F 200-100
0
Inhal M 100
75
0
F 100
75
0
52D(life)
,. it
,D .i
52D(life)
52D(life)
(103)
(103)
(103) (103)
52D(li0e)
Pt it
it it
52D(life)
if ..
52D(life) ID It
(103)
to
if
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to
(103)
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it
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if
if
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to
,,
it
52D(104)
if
52D(104)
,,
52D(104)
to it
it it
52D(104)
of it
if Pt
150 Kidney (4, 5)
30
190
150
30
190
50
50
50
50
50
50
50
50
30
30
30
30
50
50
50
50
50
50
50
50
50
50
50
50
86
85
86
86
84
88
47
48
48
80
47
48
48
80
51
30
23
30
30
16
30
30
21
30
(24/150 0/190)
NSC
NSC (4, 5)
NSC
NSC
NSC
NSCe
(4, 5)
NSCe
NSCe
NSCe
NSC (8)
NSC
NSC (8)
NSC
NSC
NSC
NSC
(9)
(9)
NSC
aChin = Chinese hamster; F344 = Fischer 344 rat; Spr-Daw
= Sprague-Dawley rat.
bGav = gavage; Inhal = inhalation.
cUnits: ppm for inhalation; mg/kg for other routes.
dNSC = Not shown to be carcinogenic.
ePreliminary results.
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Mouse, Swiss
Rat, Spr-Daw
Hamster, Chin
Mouse B6C3F1
(NCI)
Rats, F344
(NCI)
Rat, Spr-Daw
Rat, Spr-Daw
Rat, Wistar
Rat, Spr-Daw
213compound, given by gavage, was carcinogenic, in-
ducing lung tumors in both sexes and mammary
gland and uterus tumors in dosed female animals
(15). The chemical was also carcinogenic in Os-
borne-Mendel rats, giving forestomach tumors and
extrahepatic hemangiosarcomas in both sexes, sub-
cutaneous fibromas in the males and mammary
gland tumors in the females (15).
In contrast, a preliminary report by Maltoni (12)
indicated that DCE was not shown to be carcino-
genic in an inhalation study with Swiss mice and
Sprague-Dawley rats. Since there were strain and
Table 2. Bioassays of trichloroethylene (TCE).
Route Dose, Dosing period Group Target site (tumor
Species/Stra (vehicle)b Sex mg/kg (duration), wk size incidences)c Reference
Mouse B6C3F10 Gav
(Corn oil)
Mouse B6C3F1d
Rat, Osb-Mdld
Rat, Spr-Daw
Rat, Charles Riverd
Rat, Marshall
(NCI)
Rat, ACI
(NCI)
Rat, F344
(NCI)
Inhal
Gav
(Corn oil)
Gav
(Olive oil)
Inhal
Gav
(Corn oil)
Gav
(Corn oil)
Gav
(Corn oil)
M 2339
1169
0
F 1739
869
0
M 600 ppm
300 ppm
100 ppm
0
F 600 ppm
300 ppm
100 ppm
0
M 1097
549
0
F 1097
549
0
M 250
50
0
F 250
50
0
M 600 ppm
300 ppm
100 ppm
0
F 600 ppm
300 ppm
100 ppm
0
M 1000
500
0
F 1000
500
0
M 1000
500
0
F 1000
500
0
M 1000
500
0
F 1000
500
0
78D(90)
it it
it Ft
78D(90)
(i104
(104)
it
Pt
it
78D(110)
it It
78D(110)
it it
it to
52D(140)
,. it
Pt it
52D(140)
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if
,,
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(1
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(1
(110) (1
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(110)
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(110)
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,,
50
50
20
50
50
20
100
100
100
100
100
100
100
100
50
50
20
50
50
20
30
30
30
30
30
30
100
100
100
100
100
100
100
100
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
Liver, hepatocellular (10)
(31/48 26/50 1/20)
Liver, hepatocellular
11/47 4/50 0/20)
Liver, hepatocellular
(43/97 31/100 28/95 18/99)
Liver, hepatocellular
(13/99 9/94 4/100 6/99)
NSC
NSC
NSC
NSC
NSC
NSC
Assay still in progress
St. 2/79
Assay still in progress
Assay still in progress
St. 2/79
Assay still in progress
Assay still in progress
St. 6/78
Assay still in progress
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214Table 2 (cont.)
Route Dose, Dosing period Group Target site (tumor
Species/Stra (vehicle)b Sex mg/kg (duration), wk size incidences)c Reference
Rat, Osb-Mdl Gav M 1000 (110) 50 Assay still in progress
(NCI) (Corn oil) 500 it 50 St. 12/79
0 " 50
F 1000 (110) 50 Assay still in progress
500 " 50
0 " 50
Rat, August Gav M 1000 (110) 50 Assay still in progress
(NCI) (Corn oil) 500 50 St. 10/79
0 " 50
F 1000 (110) 50 Assay still in progress
500 " 50
0 " 50
Rat, B6C3F1 Gav M 1000 (110) 50 Assay still in progress
(NCI) (Corn oil) 0
i 50 St. 6/78
F 1000 (110) 50 Assay still in progress
0 " 50
aF344 = Fischer 344 rat; Osb-Mdl = Osborne-Mendel rat; Spr-Daw = Sprague-Dawley rat.
bGav = gavage, Inhal = inhalation.
CNSC = Not shown to be carcinogenic.
dWith 0.09% epichlorohydrin.
dose differences as well as route of administration
differences between the NTP/NCI and Maltoni stud-
ies, the causes ofthe differences in the experimen-
tal results are not readily apparent.
1,2-Dibromoethane (DBE)
The results of some carcinogen bioassays on DBE
are given in Table 5. In bioassays on B6C3F1 mice
and Osborne-Mendel rats, DBE given by gavage
was carcinogenic, inducing multiple tumors in each
species and sex. There were not only chemically
induced tumors at the site ofapplication (forestomach
tumors) but also tumors distant from the site of
application (lung tumors in mice and extrahepatic
hemangiosarcomas in male rats and hepatocellular
tumors in female rats) (16).
In addition, a preliminary analysis of an inhala-
tion study of DBE performed by NTP/NCI indi-
cates that nasal cavity tumors were found in dosed
rats and dosed female mice. Furthermore, elevated
incidences of lung tumors were found in the dosed
mice as well as elevatedincidences ofmammary gland
tumors in dosed females ofeach test species. Meso-
theliomas were also induced by DBE in male rats.
Epichlorohydrin (EPC)
The bioassay results on epichlorohydrin are given
in Table 6. Recently, this compound, given by
October 1981
inhalation, was found to be carcinogenic inducing
nasal cavity tumors in male rats (17). In addition,
experiments by Van Duuren (18-19) indicated that
EPC was an initiator in a two-stage study and
induced local sarcomas by subcutaneous injection.
addition more comprehensive epidemiological stud-
ies involving the manufacture, production and use
of these compounds should be undertaken.
A summary of some of the bioassay results for
each compound by species/strain is given inTable 7.
Discussion
The data on these compounds can generate some
interesting points for discussions, such as the prob-
able mechanism of some of these compounds, the
controversy over TCE results and suggestions for
future action.
In the first case, studying the summary table
indicates that the compounds (DBE, DCE, and
EPC) which are proposed to alkylate directly, gave
forestomach tumors when given by gavage or nasal
cavity tumors when given by inhalation while the
compounds which are proposed to require meta-
bolic activation did not produce these types of tu-
mors. One can envision that these compounds, due
to their alkylating ability and their ability to induce
site of application tumors, are direct-acting carcin-
ogens. Two of these former compounds, DBE and
215Table 3. Bioassays of perchloroethylene (PCE).
Route Dose, Dosing period Group Target site (tumor
Species/Stra (vehicle)b Sex mg/kg (duration), wk size incidences)c Reference
Mouse B6C3F1 Gav
(Corn oil)
Rat, Osb-Mdl
Rat, Spr-Daw
Rat, Sherman
(NCI)
Rat, Wistar
(NCI)
Rat, Long-Evans
(NCI)
Rat, F344
(NCI)
Rat, B6C3F1
(NCI)
Gav
(Corn oil)
Inhal
(Corn oil)
Gav
(Corn oil)
Gav
(Corn oil)
Gav
(Corn oil)
Gav
(Corn oil)
Gav
(Corn oil)
M 1072
536
0
F 772
386
0
M 941
471
0
F 949
474
0
M 600 ppm
300 ppm
0
F 600 ppm
300 ppm
0
M 750
375
0
F 750
375
0
M 750
375
0
F 750
375
0
M 750
375
0
F 750
375
0
M 750
375
0
F 750
375
0
F 200
100
50
25
0
78D(90)
If it
it it
78D(90)
,. it
iD if
71D(110)
,. if
if if
71D(110)
,. ..
,. ..
52D(135)
(103)
(103)
52D(135)
(103)
(103)
(103)
(103)
(103) (0
f,
(103)
,,
,,
(103)
,,
,,
(103)
(103)
,,
,,
(103)
If
If
(103)
,,
,,
(103)
,,
If
(103
,,
50 Liver, hepatocellular (13)
50
20
50
50
20
50
50
20
50
50
20
96
96
96
96
96
96
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
100
100
100
100
100
(27/48 32/49 2/20)
Liver, hepatocellular
(19/48 19/48 0/20)
NSC
NSC
NSC
NSC
Assay still in progress
St. 2/78
Assay still in progress
Assay still in progress
St. 11/78
Assay still in progress
Assay still in progress
St. 7/78
Assay still in progress
Assay still in progress
St. 9/78
Assay still in progress
Assay still in progress
SF344 = Fischer 344 rat; Osb-Mdl = O
bGav = gavage; Inhal = inhalation.
CNSC = Not shown to be carcinogenic.
)sborne-Mendel rat; Spr-Daw = Sprague-Dawley rat.
DCE, also induced tumors distant from the site of
application. This fact may be an important point in
the controversy over TCE.
This controversy stems from the fact that the
results on TCE indicated that the mice studies
were positive while the rat studies showed the
chemicaldid notproduce acarcinogeniceffect. There
have been several explanations. It has been postu-
lated that epichlorohydrin, used as a stabilizer in
the TCE tested, is responsible for the positive
effect, not TCE (21). The NCI Technical report on
TCE (10) indicated that there was 0.09% EPC in
Environmental Health Perspectives
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216Table 4. Bioassays of 1,2-dichloroethane (DCE).
Route Dose, Dosing period Group Target site (tumor Ref-
Species/Stra (vehicle)b Sex mg/kg (duration), wk size incidences)c erence
Mouse, B6C3F1 Gav M 195 78D(91) 50 Lung (15)
(Corn oil) 97 " " 50 (15/48 1/47 0/19)
0 20
F 299 78D(91) 50 Lung (15/48 7/50 1/20)
149 " " 50 Mammary gland (7/48 9/50 0/20)
0 20 Uterus (5/47 5/49 0/20)
Rat, Osb-Mdl Gav M 95 69D(110) 50 Forestomach (9/50 3/50 0/10) (15)
(Corn oil) 47 " " 50 Hemangiosarcoma (7/50 9/50 0/20)
0 20 SQ Fibroma (6/50 5/50 0/20)
F 95 69D(93) 50 Mammary gland
47 (110) 50 (18/50 1/50 0/20)
0 20
Mouse, Swiss Inhal M 250-150 ppm (life) 90 NSCd (12)
50 ppm " 90
10 ppm " 90
5 ppm " 90
0 " 180
F 250-150 ppm (life) 90 NSCd
50 ppm " 90
10 ppm " 90
5 ppm " 90
0 " 180
Rat, Spr-Daw Inhal M 250-150 ppm (life) 90 NSCd (12)
50 ppm " 90
10 ppm " 90
5 ppm
t 90
0 " 90/180
F 250-150 ppm (life) 90 NSCd
50 ppm " 90
10 ppm " 90
5 ppm " 90
0 " 90/180
aOsb-Mdl = Osborne-Mendel rat; Spr-Daw = Sprague-Dawley rat.
bGav = gavage; Inhal = inhalation.
CNSC = Not shown to be carcinogenic.
dPreliminary results.
the TCE. The doses ofTCE were about 2000-1000
mg/kg ofbody weight, corresponding to less than 2
mg/kg of body weight of epichlorohydrin. If epich-
lorohydrin is the active agent, one might expect
forestomach tumors from agavage studybecause of
its alkylating ability. However, the target site in
the mice is the liver. In addition, ifepichlorohydrin
is the carcinogen, thenwhy aretheresults negative
in the rat? Direct-acting carcinogens, like epich-
lorohydrin, are less likely to show such a species
difference than compounds which would require
metabolic activation, such as TCE itself. Thus, an
alternative explanation is that there is a species
difference reflecting some type ofmetabolic or tar-
get site sensitivity difference between the species.
The answer may be forthcoming. NTP/NCI is
testing TCE without EPC in the B6C3F1 mice and
five strains of rat. If EPC is the active compound,
the mice study should not show a carcinogenic
effect. However, if TCE is the active agent then
the B6C3F1 mouse study should be positive. The
results in the rats will also give insight into whether
there is a species or a species/strain difference for
TCE. Similar types of studies are also underway
with PCE. In addition, Maltoni has indicated that
he has started bioassays on TCE with B6C3F1 mice
and Swiss mice.
With the possible resolution of the TCE issue,
there still remains the differences in experimental
results involving vinylidine chloride (VDC). The
results in VDC may indicate that there are impor-
tant species and strain differences. As a conse-
quence, this compound may be an ideal candidate
forstudyingspecies/strain differencessystematical-
October 1981 217Table 5. Bioassays of 1,2-dibromethane (DBE).
Route Dose, Dosing period Group Target site (tumor
Species/Stra (vehicle)b Sex mg/kg (duration), wk size incidences) Reference
Mouse B6C3F1 Gav M 107 53D(78) 50 Forestomach(29/4945/500/20) (16)
(Corn oil) 62 " " 50 Lung (10/47 4/45 0/20)
0 " 20
F 107 53D(90) 50 Forestomach (28/5046/490/20)
62 " " 50 Lung (6/46 11/43 0/20)
0 (60) 20
Rat, Osb-Mdl Gav M 41 34D(49) 50 Forestomach(33/5045/500/20) (16)
(Corn oil) 38 47D" 50 Hemangiosarcoma
0 (63) 20 (4/50 11/50 0/20)
F 39 44D(61) 50 Forestomach (29/5040/500/20)
37 57D" 50 Liver, hepatocellular
0 (63) 20 (5/48 1/47 0/20)
Mouse B6C3F1 Inhal M 40 ppm (103) 50 Lung (19/46 3/48 0/41)C
(NCI) 10 ppm " 50
0 " 50
F 40 ppm (103) 50 Nasal cavity (6/50 0/50 0/50)C
10 ppm " 50 Mammary gland (8/50 14/50 2/50)C
0 " 50 Lung (37/50 5/49 1/49Y)
Rat, F344 Inhal M 40 ppm (103) 50 Nasalcavity (28/5020/500/50)c
(NCI) 10 ppm " 50 Mesothelioma
0 " 50 (25/50 7/50 1/50)c
F 40 ppm (103) 50 Nasalcavity (29/5020/500/50)c
10 ppm " 50 Mammary gland
0 " 50 (24/50 29/50 4/50)C
aF344 = Fischer 344 rat; Osb-Mdl = Osborne-Mendel rat.
bGav = gavage; Inhal = inhalation.
CPreliminary results.
Table 6. Bioassays of epichlorohydrin (EPC).
Route Dosing period Group Target site (tumor
Species/Str2 (vehicle)' Sex Dose (duration), wk size incidences)c Reference
Rat, Spr-Daw Inhal M 100 ppm 6D(life) 140 Nasal cavity (17)
30 ppm (life) 100 (15/140 2/100 0/100 0/50)
0 " 100
50
Mouse, ICR/Ha SC F 1 mg in 0.1 ml (life) 50 Local sarcomas (19)
Swiss tricaprylin (2/50 0/50)
wkly
Mouse, ICR/Ha SC F 1 mg in 0.05 ml (life) 50 Local sarcomas (18)
Swiss tricaprylin (7/50 1/50)
wkly
Mouse Skin 1 mg in 0.1 ml 1 dose 30 Initiator (18)
acetone then (10/30 3/30)
2.5 g phorbol 55D
myristatec
Mouse, C3H Skin 1 Br (life) 40 NSC (20)
Mouse, ICR/Ha Skin F 2 mg in 0.1 ml 57D(57) 50 NSC (18)
acetone 3/wk
Mouse, ICR/Ha IP F 1 mg in 0.05 ml (64) 30 NSC (18)
tricaprylin
wkly
aSpr-Daw = Sprague-Dawley rat.
bjp = intraperitoneal injection; SC = subcutaneous injection; Skin = skin painting.
CNSC = Not shown to be carcinogenic.
218 Environmental Health PerspectivesTable 7. Summary of bioassay results on vinyl chloride analogs and related compounds for some tumor sites.
VC VDC TCE PCE DCE DBE ECH
Hemangio- SD Rat-G m-CD-i Mouse-I m-OM Rat-G m-OM Rat-G
sarcoma Mouse-Ia m-CD Rat-I
Rat-Ia
Lung tumors Mouse-Ia B6C3P1-G B6C3F1-G
Rat-Ia B6C3Fl-Gb
Mammary Mouse-Ia SD Rat-I OM Rat-G F344 Rat-Ib
gland tumors B6C3F1-G B6C3F-Ib
(females)
Kidney tumors m-Sw Mouse-I
Hepatocellular B6C3F1-G B6C3F1-G f-OM Rat-G
tumors B6C3F1-I
Forestomach m-OM Rat-G OM Rat-G
tumors B6C3F1-G
Nasal cavity F344 Rat-Ib m-SD Rat-I
tumors f-B6C3Fl_Ib
Local sarcoma f-ICR/Ha Sw
Mouse-SP
NSC F344 Rat-Gb OM Rat-G OM Rat-G SD Rat-I
B6C3Fl-Gb SD Rat-G SD Rat-G Sw Mouse-I
Wis Rat-I CR Rat-I
Ch Ham-I
SD Rat-W
SD Rat-I
SD Rat-G
aEffect seen in at least two strains.
bPreliminary results on NTP/NCI studies.
ly. In addition, the differences in the NCI and
Maltoni studies on DCE could be the source for
additional research.
From an examination ofTable 7, the compounds
with positive results in multiple species yielding
multiple tumor sites are the direct acting carcino-
gens, DBE and DCE. (EPC has not been tested
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